Cardio Diagnostics-CW26CDIOWPreferred / convertible
13F holders, Q2 2024 (June 30)9holders −3
0new positions
3sold out
1famous investor
$0.07avg. 13F price*
At the end of Q2 2024, 9 institutions reported holding Cardio Diagnostics-CW26 (CDIOW) in their 13F filings, down 3 from Q1 2024. 0 opened new positions and 3 sold out. The largest holders were Boothbay Fund Management, LLC ($33K), Walleye Capital LLC ($9K) and Saba Capital Management, L.P. ($7K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Cardio Diagnostics-CW26
- CUSIP
- 14159C111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 3 | $29K |
All 13F filers, Q1 2024 → Q2 2024: 4,875 shares bought and 270,495 shares sold, net −265,620 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Boothbay Fund Management, LLC | — | No change | 60,540 | $33K |
| Walleye Capital LLC | — | No change | 234,907 | $9K |
| Saba Capital Management, L.P. | — | No change | 199,839 | $7K |
| Walleye Trading LLC | — | No change | 132,265 | $5K |
| Clear Street LLC | — | Reduce -0.1% | 83,042 | $3K |
| Context Capital Management, LLC | — | No change | 81,500 | $3K |
| D. E. Shaw & Co. | — | No change | 74,822 | $3K |
| HRT Financial LP | — | Reduce -2.5% | 36,000 | $1K |
| UBS Group AG | — | Add +95.1% | 10,001 | $390 |
"% of holder's portfolio" is CDIOW's weight in each manager's 13F, not the share of Cardio Diagnostics-CW26 the manager owns.